| Sign In to gain access to subscriptions and/or personal tools. |
Health Risks of Selected Performance-Enhancing DrugsDepartment of Pharmacy, and Executive Director, Southern Poison Center, The University of Tennessee Health Science Center, 875 Monroe Avenue, Suite 104, Memphis, TN 38163,
This article reviews adverse effects of and the difficulty of attributing toxic effects to selected drugs and dietary supplements that purportedly enhance athletic performance. On surveys estimating the extent of performance-enhancing drug use, 5% of high school students indicated anabolic-adrenergic steroid use, and approximately 28% of collegiate athletes and 5.6% of middle and high school athletes admitted creatine use. Many adverse health effects from the abuse of androgenic-anabolic steroids and androstenedione (a prodrug) are exaggerations of excessive testosterone on hepatic, cardiovascular, reproductive, and behavioral functions that can produce permanent changes. With creatine use, nausea, vomiting, diarrhea, elevated serum transaminase concentrations, hypertension, fluid retention, muscle cramping, and muscle strains have been reported. Ephedra stimulates adrenergic receptors, leading to tachycardia and hypertension, with central nervous system effects of anxiety, tremor, and hyperactivity. From 1997 to 1999, 10 people died and 13 suffered permanent disabilities due to ephedra.
Key Words: Androgenic-anabolic steroid toxicity androstenedione toxicity creatine toxicity ephedra toxicity
Journal of Pharmacy Practice, Vol. 16, No. 1,
37-44 (2003) |
|||
-Hydroxybutyrate and several prodrugs (